Evidence map›Paper›PMID 38948534›Full record

ReviewCancer innovation2024

Accelerated partial breast irradiation: Current evidence and future developments.

Dandan Song, Honghong Zhang, Chengbo Ren, Ning Zhan, Liangxi Xie, Wenjia Xie

Abstract readReview
In one paragraph

Review in Cancer innovation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dandan SongDepartment of Radiation Oncology, Xiang'an Hospital of Xiamen University, Cancer Research Center, School of Medicine Xiamen University Xiang'an Xiamen China.ORCID https://orcid.org/0009-0001-2112-9765
Honghong ZhangDepartment of Radiation Oncology, Xiang'an Hospital of Xiamen University, Cancer Research Center, School of Medicine Xiamen University Xiang'an Xiamen China.ORCID https://orcid.org/0000-0002-3893-5763
Chengbo RenDepartment of Radiation Oncology The First Affiliated Hospital of Hebei North University Zhangjiakou Hebei China.
Ning ZhanDepartment of Radiation Oncology, Xiang'an Hospital of Xiamen University, Cancer Research Center, School of Medicine Xiamen University Xiang'an Xiamen China.
Liangxi XieDepartment of Radiation Oncology, Xiang'an Hospital of Xiamen University, Cancer Research Center, School of Medicine Xiamen University Xiang'an Xiamen China.
Wenjia XieDepartment of Radiation Oncology, Xiang'an Hospital of Xiamen University, Cancer Research Center, School of Medicine Xiamen University Xiang'an Xiamen China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole breast irradiation after breast-conserving surgery for early breast cancer has become one of the standard treatment modes for breast cancer and yields the same effect as radical surgery. Accelerated partial breast irradiation (APBI) as a substitute for whole breast irradiation for patients with early breast cancer is a hot spot in clinical research. APBI is characterised by simple high-dose local irradiation of the tumour bed in a short time, thus improving convenience for patients and saving costs. The implementation methods of APBI mainly include brachytherapy, external beam radiation therapy, and intraoperative radiotherapy. This review provides an overview of the clinical effects and adverse reactions of the main technologies of APBI and discusses the prospects for the future development of APBI.

Indexed as

accelerated partial breast irradiationbrachytherapybreast cancerbreast conserving surgeryexternal beam radiation therapyintraoperative radiotherapy

Identifiers

PMID38948534
PMCPMC11212331

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.